Citation: Ah. Enk et H. Jonuleit, How do dendritic cells prevent autoimmunity: what is a mature dendritic cell in the mouse? Response, TRENDS IMMU, 22(10), 2001, pp. 547-547
Authors:
Bellinghausen, I
Brand, U
Steinbrink, K
Enk, AH
Knop, J
Saloga, J
Citation: I. Bellinghausen et al., Inhibition of human allergic T-cell responses by IL-10-treated dendritic cells: Differences from hydrocortisone-treated dendritic cells, J ALLERG CL, 108(2), 2001, pp. 242-249
Authors:
Jonuleit, H
Schmitt, E
Stassen, M
Tuettenberg, A
Knop, J
Enk, AH
Citation: H. Jonuleit et al., Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood, J EXP MED, 193(11), 2001, pp. 1285-1294
Authors:
Jonuleit, H
Giesecke-Tuettenberg, A
Tuting, T
Thurner-Schuler, B
Stuge, TB
Paragnik, L
Kandemir, A
Lee, PP
Schuler, G
Knop, J
Enk, AH
Citation: H. Jonuleit et al., A comparison of two types of dendritic cell as adjuvants for the inductionof melanoma-specific T-cell responses in humans following intranodal injection, INT J CANC, 93(2), 2001, pp. 243-251
Citation: Ah. Enk et J. Knop, T cell receptor mimic peptides and their potential application in T-cell-mediated disease, INT A AL IM, 123(4), 2000, pp. 275-281
Authors:
Jonuleit, H
Tuting, T
Steitz, J
Bruck, J
Giesecke, A
Steinbrink, K
Knop, J
Enk, AH
Citation: H. Jonuleit et al., Efficient transduction of mature CD83(+) dendritic cells using recombinantadenovirus suppressed T cell stimulatory capacity, GENE THER, 7(3), 2000, pp. 249-254
Authors:
Gollner, GP
Muller, G
Alt, R
Knop, J
Enk, AH
Citation: Gp. Gollner et al., Therapeutic application of T cell receptor mimic peptides or cDNA in the treatment of T cell-mediated skin diseases, GENE THER, 7(12), 2000, pp. 1000-1004
Citation: S. Lohmann et al., CD83(+) human dendritic cells transfected with tumor peptide cDNA by electroporation induce specific T-cell responses: A potential tool for gene immunotherapy, CANC GENE T, 7(4), 2000, pp. 605-614
Authors:
Steinbrink, K
Paragnik, L
Jonuleit, H
Tuting, T
Knop, J
Enk, AH
Citation: K. Steinbrink et al., Induction of dendritic cell maturation and modulation of dendritic cell-induced immune responses by prostaglandins, ARCH DERM R, 292(9), 2000, pp. 437-445
Authors:
Jonuleit, H
Giesecke, A
Kandemir, A
Paragnik, L
Knop, J
Enk, AH
Citation: H. Jonuleit et al., Induction of tumor peptide-specific cytotoxic T cells under serum-free conditions by mature human dendritic cells, ARCH DERM R, 292(7), 2000, pp. 325-332
Authors:
Ross, R
Jonuleit, H
Bros, M
Ross, XL
Yamashiro, S
Matsumura, F
Enk, AH
Knop, J
Reske-Kunz, AB
Citation: R. Ross et al., Expression of the actin-bundling protein fascin in cultured human dendritic cells correlates with dendritic morphology and cell differentiation, J INVES DER, 115(4), 2000, pp. 658-663
Authors:
Muller, G
Muller, A
Jonuleit, H
Steinbrink, K
Szalma, C
Paragnik, L
Lingnau, K
Schmidt, E
Knop, J
Enk, AH
Citation: G. Muller et al., Fetal calf serum-free generation of functionally active murine dendritic cells suitable for in vivo therapeutic approaches, J INVES DER, 114(1), 2000, pp. 142-148
Authors:
Jonuleit, H
Schmitt, E
Schuler, G
Knop, J
Enk, AH
Citation: H. Jonuleit et al., Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells, J EXP MED, 192(9), 2000, pp. 1213-1222
Citation: Ah. Enk et J. Knop, Amelioration of disease progression in advanced stage IV malignant melanoma with trofostamide, HAUTARZT, 51(7), 2000, pp. 486-489
Citation: Ah. Enk et J. Knop, Successful treatment of systemic lupus erythematosus with IgM-enriched immunoglobulins, HAUTARZT, 51(6), 2000, pp. 416-418
Citation: Ah. Enk et al., High dose inhalation interleukin-2 therapy for lung metastases in patientswith malignant melanoma, CANCER, 88(9), 2000, pp. 2042-2046
Authors:
Tuting, T
Steitz, J
Bruck, J
Gambotto, A
Steinbrink, K
DeLeo, AB
Robbins, P
Knop, J
Enk, AH
Citation: T. Tuting et al., Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity, J GENE MED, 1(6), 1999, pp. 400-406
Authors:
Brand, U
Bellinghausen, I
Enk, AH
Jonuleit, H
Becker, D
Knop, J
Saloga, J
Citation: U. Brand et al., Allergen-specific immune deviation from a T(H)2 to a T(H)1 response induced by dendritic cells and collagen type I, J ALLERG CL, 104(5), 1999, pp. 1052-1059
Authors:
Bellinghausen, I
Brand, U
Enk, AH
Knop, J
Saloga, J
Citation: I. Bellinghausen et al., Signals involved in the early T-H1/T-H2 polarization of an immune responsedepending on the type of antigen, J ALLERG CL, 103(2), 1999, pp. 298-306
Authors:
Kuhn, U
Brand, P
Willemsen, J
Jonuleit, H
Enk, AH
van Brandwijk-Petershans, R
Saloga, J
Knop, S
Becker, D
Citation: U. Kuhn et al., Induction of tyrosine phosphorylation in human MHC class II-positive antigen-presenting cells by stimulation with contact sensitizers (vol 160, pg 667, 1998), J IMMUNOL, 162(5), 1999, pp. 3106-3106
Citation: Ah. Enk et al., Reduced relapse rates and induction of tumor-specific immune responses by adjuvant immunotherapy in stage IV melanoma, HAUTARZT, 50(2), 1999, pp. 103-108
Authors:
Steinbrink, K
Jonuleit, H
Muller, G
Schuler, G
Knop, J
Enk, AH
Citation: K. Steinbrink et al., Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells, BLOOD, 93(5), 1999, pp. 1634-1642